Koichi Yamanishi

Q: What Schools Are Affiliated With Koichi Yamanishi

Koichi Yamanishi is affiliated with the following schools: Hokkaido University, Kitasato University, Osaka University

Koichi Yamanishi's AcademicInfluence.com Rankings

Koichi Yamanishi

Biology

#9708

World Rank

#12945

Historical Rank

Virology

#225

World Rank

#232

Historical Rank

biology Degrees

Download Badge

Biology

Koichi Yamanishi's Degrees

PhD Medical Science University of Tokyo

Why Is Koichi Yamanishi Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Koichi Yamanishi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

IDENTIFICATION OF HUMAN HERPESVIRUS-6 AS A CAUSAL AGENT FOR EXANTHEM SUBITUM (1988) (1434)
SOCS-1 participates in negative regulation of LPS responses. (2002) (681)
Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (505)
Seroepidemiology of human herpesvirus 6 infection in normal children and adults (1989) (433)
Latent human herpesvirus 6 infection of human monocytes/macrophages. (1991) (357)
Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. (1998) (341)
Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus (1989) (315)
Human herpesvirus 7: another causal agent for roseola (exanthem subitum). (1994) (278)
Varicella zoster virus infection (2015) (272)
Classification of HHV-6A and HHV-6B as distinct viruses (2014) (266)
Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. (1998) (262)
Comparison of the Complete DNA Sequences of Human Herpesvirus 6 Variants A and B (1999) (244)
Differentiation between two distinct classes of viruses now classified as human herpesvirus 6. (1991) (222)
Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection (1990) (216)
Human herpesvirus 6 (HHV‐6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV‐6 DNA (2004) (211)
Association of human herpesvirus 6 infection of the central nervous system with recurrence of febrile convulsions. (1993) (204)
Human herpesvirus 6 infection in renal transplantation. (1990) (195)
Comparison of the Complete DNA Sequences of the Oka Varicella Vaccine and Its Parental Virus (2002) (177)
Human Herpesvirus-6 Induces MVB Formation, and Virus Egress Occurs by an Exosomal Release Pathway (2008) (166)
Octamer-Binding Sequence Is a Key Element for the Autoregulation of Kaposi's Sarcoma-Associated Herpesvirus ORF50/Lyta Gene Expression (2001) (159)
Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator (2001) (159)
High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. (2002) (154)
Long-term protective immunity of recipients of the OKA strain of live varicella vaccine. (1985) (136)
Meningo‐Encephalitis Associated with HHV‐6 Related Exanthem Subitum (1990) (136)
CD134 is a cellular receptor specific for human herpesvirus-6B entry (2013) (136)
Selective amplification of cDNA sequence from total RNA by cassette-ligation mediated polymerase chain reaction (PCR): application to sequencing 6.5 kb genome segment of hantavirus strain B-1. (1992) (132)
Human herpesvirus-6 DNA in cerebrospinal fluid of a child with exanthem subitum and meningoencephalitis. (1992) (129)
Efficient Adipocyte and Osteoblast Differentiation from Mouse Induced Pluripotent Stem Cells by Adenoviral Transduction (2009) (122)
Seroepidemiological study of human herpesvirus‐6 and ‐7 in children of different ages and detection of these two viruses in throat swabs by polymerase chain reaction (1996) (121)
Transcriptional Regulation of the Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor Gene (2000) (118)
Human Herpesvirus 7 Open Reading Frame U12 Encodes a Functional β-Chemokine Receptor (2003) (117)
Human herpesvirus 7 infection associated with central nervous system manifestations. (1996) (116)
Human Herpesvirus 6 Open Reading Frame U83 Encodes a Functional Chemokine (1999) (107)
Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors. (2007) (102)
Human Herpesvirus 6 Variant A Glycoprotein H-Glycoprotein L-Glycoprotein Q Complex Associates with Human CD46 (2003) (101)
Requirement of Interaction of Nectin-1α/HveC with Afadin for Efficient Cell-Cell Spread of Herpes Simplex Virus Type 1 (2001) (100)
Human herpesviruses 6 and 7 in cervixes of pregnant women (1995) (99)
Human Herpesvirus 6 Variant A but Not Variant B Induces Fusion from Without in a Variety of Human Cells through a Human Herpesvirus 6 Entry Receptor, CD46 (2002) (97)
Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients. (1985) (96)
Human herpesvirus-6 strain groups: a nomenclature (1993) (95)
Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation (2002) (95)
The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. (2002) (94)
Synthesis and processing of glycoproteins of Varicella-Zoster virus (VZV) as studied with monoclonal antibodies to VZV antigens. (1983) (93)
Detection by polymerase chain reaction amplification of human herpesvirus 6 DNA in peripheral blood of patients with exanthem subitum (1990) (93)
Clinical manifestations associated with human herpesvirus 7 infection. (1995) (93)
New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products (1986) (92)
Accumulation of Heterochromatin Components on the Terminal Repeat Sequence of Kaposi's Sarcoma-Associated Herpesvirus Mediated by the Latency-Associated Nuclear Antigen (2004) (91)
HUMAN HERPESVIRUS 6 IN LYMPH NODES (1989) (86)
Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity (2000) (84)
Transformation of hamster embryo and human embryo cells by temperature sensitive mutants of herpes simplex virus type 2. (1974) (83)
Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children (1999) (83)
Identification and Analysis of the K5 Gene of Kaposi's Sarcoma-Associated Herpesvirus (2000) (82)
Intracellular Processing of Human Herpesvirus 6 Glycoproteins Q1 and Q2 into Tetrameric Complexes Expressed on the Viral Envelope (2004) (82)
Discovery of a Second Form of Tripartite Complex Containing gH-gL of Human Herpesvirus 6 and Observations on CD46 (2004) (82)
Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals. (2009) (78)
Demonstration of Borna disease virus RNA in peripheral blood mononuclear cells derived from Japanese patients with chronic fatigue syndrome (1996) (78)
Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice. (2009) (78)
HUMAN HERPESVIRUS 6 AND EXANTHEM SUBITUM (1988) (76)
Human herpesvirus 8‐encoded interleukin‐6 homologue (viral IL‐6) induces endogenous human IL‐6 secretion (2000) (75)
Chitosan Nanoparticle Encapsulated Hemagglutinin-Split Influenza Virus Mucosal Vaccine (2014) (73)
Viremia is present in incubation period in nonimmunocompromised children with varicella. (1985) (73)
Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. (2001) (73)
Biologic and biophysical markers of a live varicella vaccine strain (Oka): identification of clinical isolates from vaccine recipients. (1984) (72)
Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli. (2004) (71)
Analysis of a glycoprotein of human herpesvirus 6 (HHV-6) using monoclonal antibodies. (1990) (71)
Variation of DNA sequence in immediate-early gene of human herpesvirus 6 and variant identification by PCR (1994) (71)
Epidemiological study of human herpesvirus‐6 and human herpesvirus‐7 in pityriasis rosea (2000) (70)
Poly(ADP-Ribose) Polymerase 1 Binds to Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Terminal Repeat Sequence and Modulates KSHV Replication in Latency (2004) (70)
Detection of varicella-zoster virus (VZV) DNA in clinical samples from patients with VZV by the polymerase chain reaction (1991) (70)
Identification of Human Herpesvirus 6 Latency-Associated Transcripts (2002) (69)
Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor. (1998) (69)
Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome. (1995) (67)
Antigenic and genetic differentiation of the two putative types of human herpes virus 6. (1993) (66)
The Human Herpesvirus 6 U100 Gene Product Is the Third Component of the gH-gL Glycoprotein Complex on the Viral Envelope (2003) (65)
Chronic fatigue in children: clinical features, Epstein‐Barr virus and human herpesvirus 6 serology and long term follow‐up (1991) (65)
Characterization of glycoproteins of viruses causing hemorrhagic fever with renal syndrome (HFRS) using monoclonal antibodies. (1986) (64)
Exanthem subitum and antibody to human herpesvirus-6. (1989) (64)
Human herpesvirus-6 rep/U94 gene product has single-stranded DNA-binding activity. (2002) (63)
Experimental infection and immune response of guinea pigs with varicella-zoster virus (1982) (63)
Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Replication and Transcription Factor Activates the K9 (vIRF) Gene through Two Distinct cis Elements by a Non-DNA-Binding Mechanism (2002) (63)
Human herpesvirus 6 envelope cholesterol is required for virus entry. (2006) (63)
Molecular epidemiological studies of human herpesvirus 6 in families (1994) (62)
Severity of viremia and clinical findings in children with varicella. (1990) (62)
Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay. (2008) (61)
Human herpesvirus 6 induces IL‐8 gene expression in human hepatoma cell line, Hep G2 (1996) (59)
Analysis of varicella-zoster virus DNAs of clinical isolates by endonuclease HpaI. (1986) (58)
Evaluation of focus reduction neutralization test with peroxidase-antiperoxidase staining technique for hemorrhagic fever with renal syndrome virus (1984) (57)
Polypeptides of varicella-zoster virus (VZV) and immunological relationship of VZV and herpes simplex virus (HSV). (1982) (57)
Control of laboratory acquired hemorrhagic fever with renal syndrome (HFRS) in Japan. (1987) (56)
Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay. (2003) (55)
Viremic phase in nonimmunocompromised children with varicella. (1984) (55)
Human herpesvirus 6 encoded glycoprotein Q1 gene is essential for virus growth. (2010) (55)
Role of T lymphocyte subsets in protection and recovery from Hantaan virus infection in mice. (1987) (54)
Expression of Human Herpesvirus 6B repwithin Infected Cells and Binding of Its Gene Product to the TATA-Binding Protein In Vitro and In Vivo (2000) (53)
Strong interaction between human herpesvirus 6 and peripheral blood monocytes/macrophages during acute infection (2002) (52)
Prevalence of Human Herpesvirus 6 Variants A and B in Patients with Chronic Fatigue Syndrome (1994) (51)
Possible Correlation between Borna Disease Virus Infection and Japanese Patients with Chronic Fatigue Syndrome (1996) (51)
Premature apoptosis of keratinocytes and the dysregulation of keratinization in porokeratosis (2002) (51)
Human Herpesvirus 6 Open Reading Frame U14 Protein and Cellular p53 Interact with Each Other and Are Contained in the Virion (2005) (51)
Establishment of titration system for human herpesvirus 6 and evaluation of neutralizing antibody response to the virus (1989) (50)
Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world. (1998) (50)
Reactivation of human herpesvirus 6 by infection of human herpesvirus 7 (2000) (50)
Effects of human and murine interferons against hemorrhagic fever with renal syndrome (HFRS) virus (Hantaan virus). (1987) (50)
Analysis of human herpesvirus 6 glycoproteins recognized by monoclonal antibody OHV1. (1992) (49)
Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity. (2007) (48)
Primary infection of human herpesvirus 6 in children with vertical infection of human immunodeficiency virus type 1. (1999) (48)
Isolation of haemorrhagic fever with renal syndrome virus from leukocytes of rats and virus replication in cultures of rat and human macrophages. (1985) (48)
Kaposi’s sarcoma-associated herpesvirus (KSHV)-encoded vMIP-I and vMIP-II induce signal transduction and chemotaxis in monocytic cells (2003) (48)
Studies on the use of mumps virus for treatment of human cancer. (1978) (46)
Development of immunogenic recombinant Oka varicella vaccine expressing hepatitis B virus surface antigen. (1991) (45)
Detection of human herpesvirus 6 DNA in throat swabs by polymerase chain reaction (1990) (45)
Primary human herpesvirus 7 infection and exanthema subitum. (1994) (44)
Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study (2015) (44)
Persistence in the population: epidemiology and transmisson -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (43)
Human herpesvirus-6 infection induces the reorganization of membrane microdomains in target cells, which are required for virus entry. (2008) (43)
Effects of cyclosporine, azathioprine, mizoribine, and prednisolone on replication of human cytomegalovirus. (1990) (42)
Development of varicella vaccine. (2008) (42)
Cross-reactive immunity among different serotypes of virus causing haemorrhagic fever with renal syndrome. (1989) (42)
Human herpesvirus 6 and human herpesvirus 7 infections in renal transplant recipients and healthy adults in Turkey (2005) (42)
Human Herpesvirus 6 Glycoprotein Complex Formation Is Required for Folding and Trafficking of the gH/gL/gQ1/gQ2 Complex and Its Cellular Receptor Binding (2011) (42)
Cell-mediated immunity to virus causing haemorrhagic fever with renal syndrome: generation of cytotoxic T lymphocytes. (1988) (41)
Detection of human herpesvirus 7 (HHV‐7) DNA in breast milk by polymerase chain reaction and prevalence of HHV‐7 antibody in breast‐fed and bottle‐fed children (1998) (41)
Epstein-Barr virus-associated large granular lymphocyte leukemia with cutaneous infiltration. (1994) (41)
Persistent infection of rats with haemorrhagic fever with renal syndrome virus and their antibody responses. (1986) (40)
Productive human herpesvirus 6 infection causes aberrant accumulation of p53 and prevents apoptosis. (2004) (40)
Human herpesvirus 6 ganciclovir-resistant strain with amino acid substitutions associated with the death of an allogeneic stem cell transplant recipient. (2009) (40)
Recognition of a Novel Stage of Betaherpesvirus Latency in Human Herpesvirus 6 (2003) (40)
Selective Activity of Various Nucleoside and Nucleotide Analogues against Human Herpesvirus 6 and 7 (1997) (40)
Isolation of hemorrhagic fever with renal syndrome (HFRS) virus from a tumor specimen in a rat. (1983) (40)
Chronic hepatitis in an infant, in association with human herpesvirus-6 infection. (1997) (39)
Identification of a variant B-specific neutralizing epitope on glycoprotein H of human herpesvirus-6. (1997) (39)
Immunotherapy of advanced gynecologic cancer patients utilizing mumps virus. (1988) (39)
Analysis of a Neutralizing Antibody for Human Herpesvirus 6B Reveals a Role for Glycoprotein Q1 in Viral Entry (2011) (38)
Human Herpesvirus 7 Open Reading Frames U12 and U51 Encode Functional β-Chemokine Receptors (2005) (38)
Human herpesvirus 6B infection of the large intestine of patients with diarrhea. (2003) (38)
Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine. (1998) (37)
Antiherpesvirus Activities of (1′S,2′R)-9-{[1′,2′-Bis(hydroxymethyl)cycloprop-1′-yl]methyl}guanine (A-5021) in Cell Culture (1998) (37)
Analysis of human herpesvirus 6 U3 gene, which is a positional homolog of human cytomegalovirus UL 24 gene. (1998) (37)
Identification of a variant A-specific neutralizing epitope on glycoprotein B (gB) of human herpesvirus-6 (HHV-6). (1996) (36)
Detection of varicella‐zoster virus DNA in blood of children with varicella (1994) (36)
Borna Disease Virus Infection in Two Family Clusters of Patients with Chronic Fatigue Syndrome (1999) (35)
Varicella-Zoster Virus Glycoprotein M Homolog Is Glycosylated, Is Expressed on the Viral Envelope, and Functions in Virus Cell-to-Cell Spread (2007) (35)
Low incidence of Ha-ras oncogene mutations in human epidermal tumors. (1991) (35)
Experimental Infection in Newborn Mice and Rats by Hemorrhagic Fever with Renal Syndrome (HFRS) Virus (1984) (35)
Efficient adenovirus vector‐mediated PPAR gamma gene transfer into mouse embryoid bodies promotes adipocyte differentiation (2008) (35)
Human interleukin‐6 induces human herpesvirus‐8 replication in a body cavity‐based lymphoma cell line (2002) (35)
Prevalence of human herpesvirus‐8 in skin lesions (1997) (34)
Activation of human herpesvirus 8 open reading frame K5 independent of ORF50 expression. (2002) (34)
Human herpesvirus 6 meningoencephalitis with sequelae. (1995) (34)
Development of inactivated vaccine against virus causing haemorrhagic fever with renal syndrome. (1988) (34)
Human herpesvirus 6 downregulates major histocompatibility complex class I in dendritic cells (2001) (34)
Comparison of Virus Transcription during Lytic Infection of the Oka Parental and Vaccine Strains of Varicella-Zoster Virus (2006) (34)
Idiopathic thrombocytopenic purpura after human herpesvirus 6 infection (1994) (34)
Deletion in Open Reading Frame 49 of Varicella-Zoster Virus Reduces Virus Growth in Human Malignant Melanoma Cells but Not in Human Embryonic Fibroblasts (2007) (34)
Association of serine in position 1124 of Hantaan virus glycoprotein with virulence in mice. (1994) (34)
An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain. (2013) (34)
Pathogenesis of Hantaan virus in mice. (1989) (34)
VZV: pathogenesis and the disease consequences of primary infection -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (33)
Investigation of varicella‐zoster virus DNA by the polymerase chain reaction in healthy children with varicella vaccination (1994) (33)
Interferon and natural killer cell activity in patients with exanthem subitum (1992) (33)
Intranasal chitosan-DNA vaccines that protect across influenza virus subtypes. (2014) (33)
Allogeneic peripheral stem cell transplantation using positively selected CD34+ cells from HLA-mismatched donors (1998) (32)
Study of virus isolation from pharyngeal swabs in children with varicella. (1989) (32)
Studies on live mumps virus vaccine. V. Development of a new mumps vaccine "AM 9" by plaque cloning. (1973) (32)
The R3 Region, One of Three Major Repetitive Regions of Human Herpesvirus 6, Is a Strong Enhancer of Immediate-Early Gene U95 (2001) (32)
Frequent Detection of the Human Herpesvirus 6-Specific Genomes in the Livers of Children with Various Liver Diseases (2001) (32)
Isolation of human herpesvirus 7 from a child with symptoms mimicking chronic Epstein‐Barr virus infection (1993) (32)
Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus. (2008) (32)
Characterization of varicella-zoster virus-encoded ORF0 gene--comparison of parental and vaccine strains. (2010) (32)
Monitoring of human cytomegalovirus infections in pediatric bone marrow transplant recipients by nucleic acid sequence-based amplification. (1998) (31)
A community-based survey of varicella-zoster virus-specific immune responses in the elderly. (2012) (31)
Experimental infection of cynomolgus and African green monkeys with human herpesvirus 6. (1992) (31)
Complementation of the Function of Glycoprotein H of Human Herpesvirus 6 Variant A by Glycoprotein H of Variant B in the Virus Life Cycle (2012) (30)
Human Herpesvirus 6 (HHV‐6) Infection in the Central Nervous System (1992) (30)
Identification of the Oka strain of the live attenuated varicella vaccine from other clinical isolates by molecular epidemiologic analysis. (1998) (30)
Outbreak of exanthem subitum in an orphanage. (1991) (30)
[Human herpesvirus 6 (HHV-6)]. (1993) (30)
Haemagglutination-inhibition test for haemorrhagic fever with renal syndrome using virus antigen prepared from infected tissue culture fluid. (1986) (30)
Presence of antibody to human herpesvirus 6 in monkeys. (1989) (30)
Varicella zoster virus DNA in throat swabs. (1991) (30)
Comparison of antiviral assay methods using cell-free and cell-associated varicella-zoster virus. (1992) (30)
The epidemiology of KSHV and its association with malignant disease -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (29)
Comparison of nucleotide sequences of M genome segments among Seoul virus strains isolated from eastern Asia. (1994) (29)
Biologic and immunologic characterization of the soluble skin-test antigen of varicella-zoster virus. (1984) (29)
Phosphonoacetic acid inhibits replication of human herpesvirus-6. (1989) (29)
Application of live attenuated measles and mumps vaccines in children with acute leukemia. (1981) (29)
Comparison of DNA sequence and transactivation activity of open reading frame 62 of Oka varicella vaccine and its parental viruses. (2001) (28)
Prevalence of Antibody to Human Herpesvirus 6 in Women and Children (1989) (28)
Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB. (1986) (28)
Virus replication and localization of varicella-zoster virus antigens in human embryonic fibroblast cells infected with cell-free virus (1980) (28)
Deep Sequencing of Distinct Preparations of the Live Attenuated Varicella-Zoster Virus Vaccine Reveals a Conserved Core of Attenuating Single-Nucleotide Polymorphisms (2016) (28)
A posttranscriptional regulator of Kaposi's sarcoma-associated herpesvirus interacts with RNA-binding protein PCBP1 and controls gene expression through the IRES. (2004) (28)
Antigenic differences between two viruses, isolated in Japan and Korea, that cause hemorrhagic fever with renal syndrome (1984) (28)
Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus. (2007) (27)
Isolation of drug resistant mutants of varicella-zoster virus: cross resistance of acyclovir resistant mutants with phosphonoacetic acid and bromodeoxyuridine. (1983) (27)
Human Herpesvirus 6 Open Reading Frame U12 Encodes a Functional β-Chemokine Receptor (1998) (27)
Immunochemical characterization of pyrimidine kinase induced by varicella-zoster virus. (1985) (26)
Studies on live mumps virus vaccine. 3. Evaluation of newly developed live mumps virus vaccine. (1970) (26)
HHV-6A, 6B, and 7: pathogenesis, host response, and clinical disease (2007) (26)
Antiviral Activity of a Bile Pigment, Biliverdin, against Human Herpesvirus 6 (HHV‐6) In Vitro (1992) (26)
Differentiation of Oka varicella vaccine strain from wild varicella‐zoster virus strains isolated from vaccinees and household contact (1991) (26)
Varicella-Zoster Virus ORF49 Functions in the Efficient Production of Progeny Virus through Its Interaction with Essential Tegument Protein ORF44 (2013) (25)
Assessment of skin test with varicella-zoster virus antigen for predicting the risk of herpes zoster (2012) (25)
Viruses of hemorrhagic fever with renal syndrome (HFRS) grouped by immunoprecipitation and hemagglutination inhibition. (1987) (24)
Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine. (1971) (24)
Reactivation and lytic replication of KSHV -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (24)
Electron Microscopic Study of a Herpes‐Type Virus Isolated from an Infant with Exanthem Subitum (1989) (24)
Biochemical transformation of mouse cells by varicella-zoster virus. (1981) (24)
Immunization of the elderly to boost immunity against varicella-zoster virus (VZV) as assessed by VZV skin test reaction. (2001) (23)
Exanthema subitum and human herpesvirus 6 infection: clinical observations in fifty-seven cases. (1993) (23)
Poly-γ-Glutamic Acid Nanoparticles and Aluminum Adjuvant Used as an Adjuvant with a Single Dose of Japanese Encephalitis Virus-Like Particles Provide Effective Protection from Japanese Encephalitis Virus (2011) (23)
Transformation of large granular lymphocytic leukemia during the course of a reactivated human herpesvirus-6 infection. (1992) (23)
Molecular analysis of the thymidine kinase gene of thymidine kinase-deficient mutants of varicella-zoster virus. (1988) (23)
Unusually high seroprevalence of Borna disease virus in clade E human immunodeficiency virus type 1-infected patients with sexually transmitted diseases in Thailand (1996) (22)
Antigenic analysis of human herpesvirus 7 (HHV-7) and HHV-6 using immune sera and monoclonal antibodies against HHV-7. (1997) (22)
Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine. (2007) (22)
Human herpesvirus 7 infection increases the expression levels of CD46 and CD59 in target cells. (2007) (22)
VZV skin-test reaction, but not antibody, is an important predictive factor for postherpetic neuralgia. (2015) (22)
Human Herpesvirus 6 Immediate‐Early 2 Protein Interacts with Heterogeneous Ribonucleoprotein K and Casein Kinase 2 (2004) (22)
Inverse relationship between human herpesvirus-6 and -7 detection after allogeneic and autologous stem cell transplantation (2001) (22)
Endonuclease analyses of DNA of human herpesvirus‐6 isolated from blood before and after bone marrow transplantation (1992) (22)
Intranasal Immunization with a Formalin-Inactivated Human Influenza A Virus Whole-Virion Vaccine Alone and Intranasal Immunization with a Split-Virion Vaccine with Mucosal Adjuvants Show Similar Levels of Cross-Protection (2012) (22)
Human herpesviruses 6 and 7 (2013) (21)
Introduction to the human γ-herpesviruses -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (21)
Pathogenetic tropism of varicella-zoster virus to primary human hepatocytes and attenuating tropism of Oka varicella vaccine strain to neonatal dermal fibroblasts. (2003) (21)
Human herpesvirus 6-associated hemophagocytic syndrome in a healthy adult. (2002) (21)
Mechanism of host cell protection from complement in murine cytomegalovirus (CMV) infection: identification of a CMV‐responsive element in the CD46 promoter region (2002) (21)
HHV-6A, 6B, and 7: molecular basis of latency and reactivation (2007) (20)
Human Herpesvirus 6 (1992) (20)
Antibodies induced by a primary cytomegalovirus infection react with human herpesvirus 6 proteins. (1993) (20)
Efficient osteoblast differentiation from mouse bone marrow stromal cells with polylysin-modified adenovirus vectors. (2009) (20)
Molecular analysis of the Oka vaccine strain of varicella-zoster virus. (2008) (20)
The Shozu Herpes Zoster (SHEZ) Study: Rationale, Design, and Description of a Prospective Cohort Study (2012) (20)
KSHV-induced oncogenesis -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (19)
Human herpesvirus 6 envelope components enriched in lipid rafts: evidence for virion-associated lipid rafts (2009) (19)
Specificity of skin test with varicella-zoster virus antigen in varicella-zoster and herpes simplex virus infections (1987) (19)
Role of dendritic cells infected with human herpesvirus 6 in virus transmission to CD4(+) T cells. (2009) (19)
Virion and nonstructural polypeptides of human herpesvirus-6. (1989) (19)
Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children. (1984) (18)
Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after stem cell transplantation: effective monitoring of CMV infection by quantitative analysis of CMV mRNA (2001) (18)
Processing of virus-specific glycoproteins of varicella zoster virus (1985) (18)
Reciprocal roles of cellular chemokine receptors and human herpesvirus 7-encoded chemokine receptors, U12 and U51. (2007) (18)
Clinical and immunologic features of recurrent herpes zoster (HZ). (2016) (18)
Attenuation and laboratory markers of the Oka-strain varicella-zoster virus. (1985) (18)
Evidence for attachment of fatty acid to varicella-zoster virus glycoproteins and effect of cerulenin on the maturation of varicella-zoster virus glycoproteins. (1989) (18)
Detection of human alpha-herpesvirus DNA using consensus primers and specific probes. (1994) (18)
Alphaherpes viral genes and their functions -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (17)
Characterization of the Varicella-Zoster Virus ORF50 Gene, Which Encodes Glycoprotein M (2010) (17)
Novel Sensitivity of Acyclovir-Resistant Varicella–Zoster Virus to Anti-Herpetic Drugs (1990) (17)
Prokaryotic expression of an immediate-early gene of human herpesvirus 6 and analysis of its viral antigen expression in human cells. (1996) (17)
Studies on live rubella vaccine. V. Quantitative aspects of interference between rubella, measles and mumps viruses in their trivalent vaccine. (1974) (17)
Human herpesvirus 6 glycoprotein M is essential for virus growth and requires glycoprotein N for its maturation. (2012) (17)
Viral pathology of human herpesvirus 6 infection. (1990) (17)
Structure of transcripts and proteins encoded by U79-80 of human herpesvirus 6 and its subcellular localization in infected cells. (2000) (17)
Human Herpesvirus 6 Open Reading Frame U 12 Encodes a Functional b-Chemokine Receptor (1998) (17)
The seroprevalence of human herpesvirus 8 infection in the Thai population. (2002) (17)
Replication of human herpesvirus 6 (HHV-6): morphological aspects. (1990) (17)
Primate betaherpesviruses -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (17)
Identification of the major capsid protein gene of human herpesvirus 7. (1995) (17)
DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine. (2008) (17)
Immunobiology and host response -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (17)
Effects of human alpha, beta and gamma interferons on varicella zoster virus in vitro. (1994) (16)
Micro‐Neutralization Test for Mumps Virus Using the 96‐Well Tissue Culture Plate and PAP (Peroxidase‐Anti peroxidase) Staining Technique (1985) (16)
Expression of varicella-zoster virus-related antigens in biochemically transformed cells. (1983) (16)
Epidermolysis bullosa simplex (Weber-Cockayne) associated with a novel missense mutation of Asp328 to Val in Linker 12 domain of keratin 5. (1995) (16)
Comparative analysis of herpesvirus-common proteins -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (16)
Immunosuppressive dose of azathioprine inhibits replication of human cytomegalovirus in vitro (2005) (16)
Isolation of varicella‐zoster virus from vesicles in children with varicella (1996) (16)
Nucleotide sequence of the M genome segment of hemorrhagic fever with renal syndrome virus strain B-1. (1990) (16)
Human herpesvirus 7 U47 gene products are glycoproteins expressed in virions and associate with glycoprotein H. (2006) (15)
Comparative virion structures of human herpesviruses -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (15)
Real-time PCR determination of human herpesvirus 6 antiviral drug susceptibility. (2007) (15)
Cataloging of the genes expressed in human keratinocytes: analysis of 607 randomly isolated cDNA sequences. (1994) (15)
Comparative analysis of the genomes -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (15)
Identification and characterization of human herpesvirus 8 open reading frame K9 viral interferon regulatory factor by a monoclonal antibody. (1999) (15)
Development of fiber-substituted adenovirus vectors containing foreign peptides in the adenovirus serotype 35 fiber knob (2009) (15)
Processing of hepatitis B virus surface antigen expressed by recombinant Oka varicella vaccine virus. (1992) (14)
Reactivation of latent human immunodeficiency virus 1 by human herpesvirus 6 infection. (2007) (14)
Susceptibility to acyclovir of Oka-strain varicella vaccine and vaccine-derived viruses isolated from immunocompromised patients. (1984) (14)
Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps virus Urabe vaccine strain. (1997) (14)
Seroprevalence of human herpesvirus 6 and 7 infections in the Thai population. (1995) (13)
Characterization of neutralizing monoclonal antibody escape mutants of Hantaan virus 76118 (1998) (13)
Entry of alphaherpesviruses into the cell -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (13)
Characterization of human herpesvirus 7 U27 gene product and identification of its nuclear localization signal. (2000) (13)
Studies on live attenuated mumps virus vaccine. II. Biological characteristics of the strains adapted to the amniotic and chorioallantoic cavity of developing chick embryos. (1970) (13)
Kaposi's sarcoma-associated herpesvirus (KSHV) sequences in premalignant and malignant skin tumors (2005) (13)
Detection of a Gene Cluster That Is Dispensable for Human Herpesvirus 6 Replication and Latency (2003) (13)
Human herpesvirus 6 and intussusception. (1993) (13)
Identification and analyses of glycoprotein B of human herpesvirus 7. (1996) (13)
A viral transcriptional activator of Kaposi's sarcoma-associated herpesvirus (KSHV) induces apoptosis, which is blocked in KSHV-infected cells. (2003) (13)
Pathogenesis and disease -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (13)
DO SECOND ATTACKS OF EXANTHEMA SUBITUM RESULT FROM HUMAN HERPESVIRUS 6 REACTIVATION OR REINEFCTION? (1991) (13)
Enhancement of host cell reactivation of ultraviolet‐irradiated herpes simplex virus by caffeine, hydroxyurea and 5‐bromodeoxyuridine (1979) (12)
The epidemiology and pathogenesis of infections caused by the high numbered human herpesviruses in children: HHV-6, HHV-7 and HHV-8. (1999) (12)
Establishment and characterization of the T-cell line, EBT-8 latently infected with Epstein-Barr virus from large granular lymphocyte leukemia. (1994) (12)
Immune response of guinea pigs to varicella vaccine strain (OKA) and wild strains. (1980) (12)
Characterization of Glycoprotein H and L of Human Herpesvirus 7 (1997) (12)
Varicella infection complicated with meningitis after immunization (1993) (12)
Genetic polymorphism of human herpesvirus-7 among human populations. (2001) (11)
Identification of human herpesvirus 6 uracil-DNA glycosylase gene. (1994) (11)
Sleep Shortage Is Associated With Postherpetic Neuralgia Development Through Hyperesthesia and Acute Pain Intensity: A Community‐Based Prospective Cohort Study (2019) (11)
Cytomegalovirus retinitis after transplantation of positively selected CD34+ cells from HLA-mismatched donors. (1998) (11)
HHV-6A, 6B, and 7: persistence in the population, epidemiology and transmission -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (11)
High rate of reactivation of human herpesvirus 6 in children with dengue hemorrhagic fever. (1994) (11)
Physicochemical characterization of human herpesvirus 6 infectivity. (1991) (11)
Relationship between cell‐mediated immunity to Varicella–Zoster virus and aging in subjects from the community‐based Shozu Herpes Zoster study (2017) (11)
Cytomegalovirus Hepatitis Confirmed by In Situ Hybridization in 3 Immunocompetent Infants (2001) (11)
An MDCK Cell Culture-Derived Formalin-Inactivated Influenza Virus Whole-Virion Vaccine from an Influenza Virus Library Confers Cross-Protective Immunity by Intranasal Administration in Mice (2013) (11)
Virus entry into host, establishment of infection, spread in host, mechanisms of tissue damage -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (11)
Human herpesvirus‐6 infection in neonates: Not protected by only humoral immunity (2002) (10)
Pathogenesis of human herpesvirus 6 (HHV-6). (1992) (10)
Early events in human cytomegalovirus infection -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (10)
Varicella-zoster virus ORF1 gene product is a tail-anchored membrane protein localized to plasma membrane and trans-Golgi network in infected cells. (2008) (10)
Associations of Perceived Mental Stress, Sense of Purpose in Life, and Negative Life Events With the Risk of Incident Herpes Zoster and Postherpetic Neuralgia: The SHEZ Study (2018) (10)
Influenza virus neuraminidase contributes to the dextran sulfate-dependent suppressive replication of some influenza A virus strains. (2012) (10)
Relationship between U83 gene variation in human herpesvirus 6 and secretion of the U83 gene product (2009) (10)
Delayed-type hypersensitivity and in vitro lymphocyte response in guinea pigs immunized with a live varicella vaccine. (1984) (10)
Molecular basis of HSV latency and reactivation -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (9)
Exanthem subitum and human herpesvirus 6 (HHV-6) infection. (1990) (9)
Association of cigarette smoking with a past history and incidence of herpes zoster in the general Japanese population: the SHEZ Study (2017) (9)
Identification of the Human Herpesvirus 6A gQ1 Domain Essential for Its Functional Conformation (2013) (9)
Transformation of a hamster embryo cell line (Nil) with a host-dependent mutant of adenovirus type 5. (1974) (9)
Overview of classification -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (9)
Highlights from 5th International Conference on HHV-6 and -7. (2006) (9)
Varicella‐Zoster Virus (VZV)‐Specific Polypeptides Detected in Cells Treated with Metabolic Inhibitors (1985) (9)
Experimental labyrinthitis in guinea pigs caused by a hantavirus. (1991) (9)
Thymidine kinase with altered substrate specificity of acyclovir resistant varicella-zoster virus. (1986) (9)
Immediate–early viral gene regulation and function -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (9)
Functional analysis of Kaposi's sarcoma-associated herpesvirus RTA in an RTA-depressed cell line. (2001) (9)
Antiviral therapy of HSV-1 and -2 -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (8)
Comparison of immunofluorescence and hemagglutination inhibition tests and enzyme-linked immunosorbent assay for detection of serum antibody in rats infected with hemorrhagic fever with renal syndrome virus (1986) (8)
The evidence of human herpesvirus 6 infection in the lymph nodes of Hodgkin's disease (2005) (8)
Human herpesvirus 6 major immediate early promoter has strong activity in T cells and is useful for heterologous gene expression (2011) (8)
Enhancement of infectivity of hantavirus in cell culture by centrifugation. (1994) (8)
Comparison of the cross-reactive anti-influenza neutralizing activity of polymeric and monomeric IgA monoclonal antibodies. (2012) (8)
Nucleotide sequence analysis of a 30-kilobase-pair region of human herpesvirus-6B (HHV-6B) genome and strain-specific variations in major immediate-early genes. (1997) (8)
Analysis of p53 gene mutations and loss of heterozygosity for loci on chromosome 9q in basal cell carcinoma. (1994) (8)
Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay. (2015) (8)
Effect of FK-506 on replication of human cytomegalovirus in vitro. (1991) (8)
Genetic comparison of human alphaherpesvirus genomes -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (8)
Studies on live attenuated mumps virus vaccine. 1. Attenuation of mumps virus by serial passage in the chorioallantoic cavity of developing chick embryos and field trials by the inhalation method. (1970) (8)
Positive and negative regulation of adenovirus infection by CAR-like soluble protein, CLSP (2007) (8)
Immune Reactivity of Human Sera to the Glycoprotein B of Human Herpesvirus 7 (2002) (7)
Human Herpesvirus 6 (HHV‐6) Infection and Exanthem Subitum in Thailand (1991) (7)
Transcription Mapping of Glycoprotein I (gpI) and gpIV of Varicella‐Zoster Virus and Immunological Analysis of the gpI Produced in Cells Infected with the Recombinant Vaccinia Virus (1989) (7)
Chromosomal loci of 50 human keratinocyte cDNAs assigned by fluorescence in situ hybridization. (1995) (7)
Antibody response to the immediate early protein of cytomegalovirus in renal transplant recipients (1991) (7)
Maturation and egress -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (7)
Immunofluorescence, enzyme-linked immunosorbent assay, particle agglutination and western blot for the detection of antibody to human immunodeficiency virus type 1. (1990) (7)
Nasal antibody response to mumps virus after vaccination and natural infection. (1992) (7)
Novel polyvalent live vaccine against varicella–zoster and mumps virus infections (2013) (7)
Herpesvirus DNA in Peripheral Blood Mononuclear Cells of Some Patients with Meniere's Disease (2001) (7)
Varicella zoster virus DNA in throat swabs of vaccinees. (1992) (7)
Rapid and efficient introduction of a foreign gene into bacterial artificial chromosome-cloned varicella vaccine by Tn7-mediated site-specific transposition. (2010) (7)
[Symptoms, signs and laboratory findings in patients with chronic fatigue syndrome]. (1992) (7)
Human Herpesvirus 6 Variant A but Not Variant B Induces Fusion from Without in a Variety of Human Cells through a Human Herpesvirus 6 Entry Receptor , CD 46 (2002) (7)
The association of skin diseases with human herpesvirus 8 infection in HIV carriers (1998) (6)
Comparative genome and virion structure -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (6)
Varicella-zoster virus ORF 58 gene is dispensable for viral replication in cell culture (2008) (6)
Human gammaherpesvirus immune evasion strategies -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (6)
Detection of Epstein-Barr virus DNA and HHV-6 DNA in tissue biopsies from patients with nasopharyngeal carcinoma by polymerase chain reaction. (1993) (6)
KSHV gene expression and regulation -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (6)
Persistence of protective immunity after inoculation with live varicella vaccine (strain Oka). (1984) (6)
Dextran sulfate-resistant A/Puerto Rico/8/34 influenza virus is associated with the emergence of specific mutations in the neuraminidase glycoprotein. (2014) (5)
Genetic variations of human herpesvirus 7 by analysis of glycoproteins B and H, and R2‐repeat regions (2002) (5)
Early events pre-initiation of alphaherpes viral gene expression -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (5)
Molecular basis of persistence and latency -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (5)
Human herpesvirus 6 and human herpesvirus 7. (2009) (5)
EBV and KSHV – related herpesviruses in non-human primates -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (5)
Experimental labyrinthitis in rats caused by infecting with virus causing hemorrhagic fever with renal syndrome (HFRS). (1989) (5)
Gammaherpesviruses entry and early events during infection -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (5)
Human Herpesvirus 6: an Evolving Story. (2000) (5)
Antiviral therapy of varicella-zoster virus infections -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (4)
Trial of split-product trivalent influenza vaccine in high-risk children. (1982) (4)
Quantification of a cell-mediated immune response against varicella zoster virus by assessing responder CD4high memory cell proliferation in activated whole blood cultures. (2019) (4)
VZV: molecular basis of persistence (latency and reactivation) -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (4)
Prevalences of human herpesvirus 6 and human herpesvirus 7 in normal Thai population. (1999) (4)
Effects of varicella zoster virus or herpes simplex virus type I infection in vitro on response of human peripheral blood mononuclear cells to phytohemagglutinin. (1995) (4)
Susceptibilities of phosphonoacetic acid and acyclovir resistant varicella-zoster virus mutants to 9-beta-arabinofuranosyladenine and 1-beta-arabinofuranosylcytosine. (1986) (4)
Induction of cellular DNA synthesis by a temperature-sensitive mutant of herpes simplex virus type 2. (1975) (4)
Vaccines and immunotherapy (2007) (4)
Detection of Human Herpesvirus 6 DNA in Clinical Samples of Patients by Polymerase Chain Reaction Amplification (1992) (4)
Early viral gene expression and function -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (4)
[Human herpes virus 6 (HHV-6)]. (1991) (4)
[Ligase chain reaction (LCR)]. (1993) (4)
Initiation of transcription and RNA synthesis, processing and transport in HSV and VZV infected cells -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (4)
[Chronic fatigue syndrome and virus infection: human herpesvirus 6 (HHV-6) infection]. (1992) (3)
New approaches to antiviral drug discovery (genomics/proteomics) -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (3)
Immunobiology and host response to KSHV infection -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (3)
Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K 5 protein encoded by Kaposi ’ s sarcoma-associated herpesvirus / human herpesvirus-8 (3)
Simian varicella virus -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (3)
Herpesviruses as therapeutic agents -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (3)
Novel monoclonal antibodies for identification of multicentric Castleman's disease; Kaposi's sarcoma-associated herpesvirus-encoded vMIP-I and vMIP-II. (2012) (3)
Monkey B virus -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (3)
DNA synthesis and late viral gene expression -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (3)
Herpesvirus-6 (HHV-6) Encephalitis in a Child Presenting as a Focal Necrotic Lesion (1999) (3)
Development of human monoclonal antibodies against human cytomegalovirus. (1992) (3)
Envelopment of herpes simplex virus nucleocapsids at the inner nuclear membrane -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (3)
VSV: persistence in the population -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (3)
Alphaherpesvirus DNA replication -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (3)
Differential detection of human papillomavirus DNA type 6 and 11 amplified by polymerase chain reaction. (1990) (3)
Effects on apoptosis, cell cycle and transformation, and comparative aspects of EBV with other known DNA tumor viruses -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (2)
Herpes simplex vaccines -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (2)
Immunopathological aspects of HSV infection -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (2)
[Chronic fatigue syndrome (CFS)]. (2001) (2)
HCMV persistence in the population: potential transplacental transmission -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (2)
Systemic Deposition of Viral Antigens in the Vascular Endothelia of Hemorrhagic Fever with Renal Syndrome (1987) (2)
Studies on live rubella vaccine. IV. Comparative field trials with attenuated vaccines at different passage levels in Japanese quail embryo fibroblast cells. (1973) (2)
Gammaherpesviruses of New World primates -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (2)
Live attenuated SARS-CoV-2 vaccine candidate: Protective immunity without serious lung lesions in Syrian hamsters (2021) (2)
Studies on live attenuated mumps vaccine. III. Long-term follow-up study on the efficacy of Biken vaccine. (1982) (2)
DNA binding proteins induced by varicella-zoster virus in human cells. (1982) (2)
Varicella-zoster vaccine -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (2)
Sequential measurement of human herpesvirus 6 DNA with polymerase chain reaction method in pediatric living‐related liver transplantation (2001) (2)
Comparative assay of varicella skin test antigens by the ELISA and RPHA tests. (1990) (2)
Chapter 12 Exanthem subitum and HHV-6 infection (1992) (2)
[Mumps virus therapy of neoplasms (2)]. (1977) (2)
Subversion of innate and adaptive immunity: immune evasion from antibody and complement -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (2)
[Defection of viral DNA in latent infection of HHV-6]. (1990) (2)
Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity (2022) (2)
Human herpesvirus-6 rep / U 94 gene product has single-stranded DNA-binding activity (2)
Characterization of Hantaviruses using monoclonal antibodies. (1987) (2)
Deoxythymidine kinases in varicella-zoster virus infected and biochemically transformed cells. (1982) (2)
[Human herpesvirus 6 and 7 infections]. (1998) (2)
Antiviral therapy for human cytomegalovirus -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (2)
[Clinical features of hemorrhagic fever with renal syndrome (epidemic hemorrhagic fever) in Japan: a clinical and laboratory study on 27 cases in Osaka in the 1960's and the 1980's]. (1985) (2)
EFFECTS OF HUMAN a, 13 AND Y INTERFERONS ON VARICELLA ZOSTER VIRUS IN VITRO (1994) (1)
Epstein–barr virus vaccines -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (1)
E Possible correlation between Borna disease virus infection and Japanese patients with chronic fatigue syndrome. (1996) (1)
The R 3 Region , One of Three Major Repetitive Regions of Human Herpesvirus 6 , Is a Strong Enhancer of Immediate-Early Gene U 95 (2001) (1)
Clinical and pathological aspects of EBV and KSHV infection -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (1)
Human cytomegalovirus vaccines -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (1)
DNA vaccines for human herpesviruses -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (1)
Regulation of Thymidine Kinase Activity in Mouse L Cells Biochemically Transformed by Varicella‐Zoster Virus (1989) (1)
Risk of Herpes Zoster in Relation to Body Mass Index Among Residents Aged ≥50 Years: The Shozu Herpes Zoster Study (2021) (1)
Neuraminidase gene homology contributes to the protective activity of influenza vaccines prepared from the influenza virus library. (2014) (1)
Herpesvirus evasion of T-cell immunity -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (1)
Maintenance and replication during latency -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (1)
Mild Reduction of Generalized Rash in Guinea Pigs Experimentally Infected with Varicella Zoster Virus or Herpes Simplex Virus Type 1 (1995) (1)
[Detection and analysis of human herpesvirus genomes by polymerase chain reaction]. (1996) (1)
Spread of Herpes Simplex Virus Type 1 / HveC with Afadin for Efficient Cell-Cell α Requirement of Interaction of Nectin-1 (2001) (1)
Infections post transplant Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation (2002) (1)
E Demonstration of Borna disease virus RNA in peripheral blood mononuclear cells derived from Japanese patients with chronic fatigue syndrome. (1996) (1)
Enhancement of plaque formation of herpes simplex virus (HSV) and varicella-zoster virus (VZV) by subinhibitory dose of acyclovir (ACV). (1989) (1)
Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children. (1986) (1)
The egress of alphaherpesviruses from the cell -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (1)
[Detection of human herpesvirus 6 (HHV-6) DNA by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) of HHV-6 DNA]. (1992) (1)
Candidate anti-herpesviral drugs; mechanisms of action and resistance -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (1)
Human herpesvirus 7 and human herpesvirus 6 reactivated in pityriasis rosea patient (1998) (1)
[New human herpesvirus, human herpes virus-6]. (1989) (1)
Studies on live mumps virus vaccine. IV. Clinical and serological follow-up 2 year and 3 years after vaccination. (1971) (1)
Development of inactivated vaccine of hemorrhagic fever with renal syndrome (HFRS) virus (1988) (1)
[Perspective of development of vaccine against infectious diseases]. (2011) (1)
Human Herpesviruses: Preface (2007) (0)
Human Herpesvirus 6 Glycoprotein Complex Formation Is Required for Folding and Trafﬁcking of the gH/gL/gQ1/gQ2 Complex and Its Cellular Receptor Binding (cid:1) (2011) (0)
173 BCL-XL activates human transglutaminase 1 promoter in keratinocytes (1997) (0)
New human herpesviruses; human herpesvirus 6 and 7 (1995) (0)
172 Targeted disruption of the transglutaminase 1 gene (1997) (0)
Immunotherapy of HSV infections – antibody delivery -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (0)
[Crosstalking between HIV and HHV-8 via IL-6 in AIDS]. (2000) (0)
Presence of Human Herpesvirus 6 and 7 DNAs in Cervixes of Pregnant Women in Late Pregnancy (1995) (0)
Characterization of Glycoproteins of Viruses Causing Hemorrhagic Fever with Renal Syndrome (HFRS) and Classification of HFRS-Related Viruses Using Monoclonal Antibodies (1986) (0)
[Tissue culture of human skin--a review of experimental methods and applications to dermatologic problems]. (1988) (0)
From the Co-Chairs of the 5th International Conference on HHV-6 & 7 (2006) (0)
081 A novel mutation of ASP328 to valin linker 12 domain of keratin 5 in a japanese family of Weber-Cockayne type epidermolysis bullosa simplex (1995) (0)
A recombinant varicella vaccine harboring a respiratory syncytial virus gene induces humoral immunity. (2015) (0)
Infection of undifferentiated and differentiated promyelocytic cells (HL-60) with varicella-zoster virus. (1988) (0)
[Structure and functional analysis of genomes of herpesviruses: varicella-zoster virus]. (1989) (0)
Comparison of the Complete DNA Sequences of the Oka Varicella Vaccine and Its Parental Virus (2003) (0)
Perspective for vaccine against infectious diseases (2008) (0)
STUDIES ON THE LIVE ATTENUATED MUMPS VIRUS VACCINE (1971) (0)
[Antigenic analysis of hemorrhagic fever with renal syndrome viruses (HFRS) using monoclonal antibodies]. (1987) (0)
Hantavirus Infection of the Inner Ear (1988) (0)
Study on mechanism of cell fusion induced by HHV-6 (2004) (0)
Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster. (1986) (0)
Screening for Ha-ras oncogene mutations in human epidermal tumors by polymerase chain reaction (1990) (0)
Chitosan Nanoparticle Encapsulated Hemagglutinin-Split Influenza Virus Mucosal Vaccine (2013) (0)
Identiﬁcation and Analysis of the K5 Gene of Kaposi’s Sarcoma-Associated Herpesvirus (2000) (0)
, Cell-to-Cell Spread the Viral Envelope , and Functions in Virus Homolog Is Glycosylated , Is Expressed on Varicella-Zoster Virus Glycoprotein (2007) (0)
Longitudinal changes in cell‐mediated immunity after varicella‐zoster virus skin test in the general population; Shozu Herpes Zoster Study: SHEZ study (2022) (0)
Human Herpesvirus 7 Open Reading Frame U12 Encodes a Functional (cid:2) -Chemokine Receptor (2003) (0)
Adoptive immunotherapy for herpesviruses -- Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (2007) (0)
[Tissue affinity of pathogens: virus latent infections and their recurrence]. (1986) (0)
Changes in types of collagen in the process of burn wound healing in guinea pigs (1990) (0)
Gene 62 of the attenuated varicella virus Oka strain and methods of identifying an attenuated, live varicella virus strain using this gene. (1999) (0)
[Classification of HFRS viruses]. (1989) (0)
Inner Ear Pathology due to Hantaviruses (1987) (0)
HERPESVIRUSES 6 AND 7 - HUMAN (HERPESVIRIDAE) (1999) (0)
Immunogenicity of varicella-zoster virus vaccine by different routes of administration: Comparable vaccination efficacy of one-fifth dose intradermal vaccination to conventional subcutaneous vaccination. (2022) (0)
[Mumps virus therapy of neoplasms (1)]. (1977) (0)
Classification of HHV-6A and HHV-6B as distinct viruses (2013) (0)
A method for controlling the quality of an attenuated varicella live vaccine (2001) (0)
Investigation on upper gastrointestinal lision in herpes zoster (1991) (0)
[Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. f. Varicella-zoster virus]. (1987) (0)
212 The feasibility of non-isotopic in situ hybridization in paraffin embedded skin tissues (1995) (0)
Subject Index, Vol. 29, 1988 (1988) (0)
Human Herpesviruses: List of contributors (2007) (0)
The association of family history of herpes zoster and the risk of incident herpes zoster: the SHEZ Study (2022) (0)
Viral complications Inverse relationship between human herpesvirus-6 and -7 detection after allogeneic and autologous stem cell transplantation (2001) (0)
Strand‐Specific Detection of Hantaan Virus RNA Sequences by In Vitro DNA Amplification (1994) (0)
Studies on the combined use of killed and live measles vaccines. IV. Fou years follow-up. (1969) (0)
Kit comprising reagents for amplification and detection of nucleic acids from cytomegalovirus (CMV) with the nucleic acid sequence ss2.7 (1997) (0)
Pathogenicity of Human Herpesvirus-6 (1994) (0)
The Antiviral Action of Ara-A on Varicella-zoster Virus (1984) (0)
Detection of varicella zoster virus DNA by polymerase chain reaction in clinical samples from patients with Hunt's syndrome. (1994) (0)
Regulation of human epidermal transglutaminase gene: The 5′ flanking region mediates tissuespecific expression in keratinocytes (1992) (0)
[Clinical features, laboratory data and anti-viral antibody titers in a severe case of hemorrhagic fever with renal syndrome (HFRS)--a one-month course from onset]. (1986) (0)
Evaluation ofFocusReduction Neutralization TestwithPeroxidase- Antiperoxidase Staining Technique forHemorrhagic Feverwith RenalSyndrome Virus (1984) (0)
Human Herpesviruses: Plate section (2007) (0)
Studies on further attenuated liver measles vaccine. VI. Clinical and serological follow-up one year after vaccination. (1971) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Koichi Yamanishi?

Koichi Yamanishi is affiliated with the following schools: